Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases: a Multicenter Cohort Study

NCT06023173 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06023173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases: a Multicenter Cohort Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
October 1, 2013
Completion date
January 1, 2023
Enrollment
307 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the patients with crlm who benefit more from bevacizumab